Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

SEC Filings

This part of our website contains archival information which will not be considered current and may no longer be accurate.

Filing date	Form	Description	Filing Group	Downloads
05/12/20	4	Statement of changes in beneficial ownership of securities	3,4,5	0001127602-20-016261.rtf 0001127602-20-016261.xls 0001127602-20-016261.pdf
05/12/20	4	Statement of changes in beneficial ownership of securities	3,4,5	0001127602-20-016265.rtf 0001127602-20-016265.xls 0001127602-20-016265.pdf
05/08/20	4	Statement of changes in beneficial ownership of securities	3,4,5	0001127602-20-015882.rtf 0001127602-20-015882.xls 0001127602-20-015882.pdf
05/08/20	8-K	Report of unscheduled material events or corporate event	Current Reports	0001100682-20-000014.rtf 0001100682-20-000014.xls 0001100682-20-000014.pdf EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
05/07/20	8-K	Report of unscheduled material events or corporate event	Current Reports	0001157523-20-000692.rtf 0001157523-20-000692.xls 0001157523-20-000692.pdf EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
05/07/20	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	0001100682-20-000012.rtf 0001100682-20-000012.xls 0001100682-20-000012.pdf EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
05/04/20	4	Statement of changes in beneficial ownership of securities	3,4,5	0001127602-20-015124.rtf 0001127602-20-015124.xls 0001127602-20-015124.pdf
03/26/20	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	Proxy Filings	0001047469-20-001792.rtf 0001047469-20-001792.xls 0001047469-20-001792.pdf
03/06/20	4	Statement of changes in beneficial ownership of securities	3,4,5	0001127602-20-009777.rtf 0001127602-20-009777.xls 0001127602-20-009777.pdf
03/04/20	8-K	Report of unscheduled material events or corporate event	Current Reports	0001100682-20-000008.rtf 0001100682-20-000008.xls 0001100682-20-000008.pdf EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.

Featured Report

Charles River Corporate Citizenship Report
View PDF
Print PDF